1 of 1

Metastasis of Prostate Cancer to the Optic Canal

  • PCa is the second most common diagnosed cancers (14%) and the second leading cause of cancer death in United States males, with average lifetime risk of 12.5% (1 in 8) and a mortality rate of 0.189% (18.9 in 100,000)1,2
  • With an emphasis on early detection, only a small percentage of PCa present with distant disease1,2
  • Ocular Metastases occur in 1-4.7% of metastatic cancer patients. A rate that is change with improving chemotherapy3
  • Here, we review cases of PCa with an optic canal metastasis
  • Retrospective literature review and pooled analysis
  • Sub-group analysis of the initial presentation (IP) cases and the after diagnosis (AD) cases
  • Ocular metastases are high-unusual, but can be the initially presentation for PCa the involvement of other structures, such as the axial skeleton (e.g. pelvis and spine)
  • Symptoms such as diplopia and proptosis were more common for an initial presentation, whereas visual acuity and vision loss were not significantly different between groups
  • We identified 45 case of published reports of patients with prostate cancer with metastasis to the optic canal, including one from our institution
  • 20 cases (44%) presented with ocular metastasis in the initial presentation
  • The average age of cases is 66.8-years-old which coincides with the national median age of 67-years-old
  • Thirteen cases (29%) involved with additional ocular metastases to either the optic nerve, optic disc, choroid, or orbit
  • Thirty-two cases reported mortality data, with sixteen reporting patient death after diagnosis (50%)
  • One case (2.2%) involved solitary lesions to the optic nerves bilaterally and only
  • Thirty-seven cases reported primary adenocarcinoma on histology (95%)

Methods

Discussion

Conclusion

Neil Kelkar BS1, Jue Wang MD, FACP2,3,4

Introduction: Metastatic Prostate Cancer (PCa)

1 University of Arizona College of Medicine– Phoenix, Phoenix, Arizona, USA

2 Creighton University School of Medicine, Phoenix, Arizona, USA

3 St. Joseph's Hospital and Medical Center, Phoenix, Arizona, USA

4 Dignity Health Cancer Institute, St. Joseph’s Hospital and Medical Center, Phoenix, Arizona, USA

Results

Figure

1. Key Statistics for Prostate Cancer | Prostate Cancer Facts [Internet]. [cited 2022 Apr 29]. Available from: https://www.cancer.org/cancer/prostate-cancer/about/key-statistics.html

2. Cancer of the Prostate - Cancer Stat Facts [Internet]. SEER. [cited 2022 Apr 29]. Available from: https://seer.cancer.gov/statfacts/html/prost.html

3. Cohen VML. Ocular metastases. Eye (Lond). 2013 Feb;27(2):137–41.

  • Ocular metastases are probably underdiagnosed and underlying molecular events are poorly understood
  • Because early diagnosis and prompt management may positively alter the prognosis for these patients, ophthalmologists should be aware of this entity
  • With advances in systemic treatments  and local modalities, tumor control and vision preservation can be increasingly efficient
  • The combination of systemic and local treatments is complex and highly dependent on the presentation of the ocular metastasis and patient‘s prognosis 
  • Before large evidence-based studies are available, the role of multidisciplinary team involvement should be emphasized

References

Tables

Figure 1: Gleason Score Breakdown Between Subsets

Symptom Reported

Initial Presentation Subset (%)

After Diagnosis Subset (%)

P-Value

Decreased Visual Acuity

45

48

0.421

Proptosis

55

28

0.0365

Vision Loss

20

44

0.0484

Diplopia

35

12

0.0360

Periorbital swelling

20

4

0.0485

Reported retinal findings

20

4

0.0485

Table 2: Breakdown of Reported Symptoms of Published Cases of Metastatic Prostate with Optic Canal Involvement

Initial Presentation

After Diagnosis

Overall

Number of Cases

20

25

45

Average Age

69.5

64.5

66.8

Median PSA

151.5 (n=7)

115 (n=7)

140

Mortality

6 (38%)

10 (63%)

16 (50%)

Bony Mets

13 (40%)

10 (40%)

23(49%)

Ocular Mets

5 (25%)

8 (32%)

13 (20%)

Table 1: Breakdown of Clinical Characteristics

Click to edit Master title style